Niloren Capsule 200 mg contains Nilotinib, a tyrosine kinase inhibitor (TKI) used in the treatment of chronic myeloid leukemia (CML). Nilotinib works by selectively inhibiting the BCR-ABL protein, which is responsible for abnormal growth of leukemia cells. Niloren is prescribed for patients with Philadelphia chromosome-positive CML, helping to control disease progression, achieve remission, and improve long-term survival.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Niloren Capsule 200 mg is indicated for:
Philadelphia chromosome-positive chronic myeloid leukemia (CML)
Adult patients newly diagnosed with chronic phase CML
Patients resistant or intolerant to prior therapy with imatinib
Management of disease progression prevention in CML
Nilotinib works by:
Inhibiting the BCR-ABL tyrosine kinase, which drives leukemia cell proliferation
Blocking signaling pathways responsible for uncontrolled cell division
Reducing the number of leukemia cells in the blood and bone marrow
Providing targeted therapy with higher specificity and efficacy compared to conventional chemotherapy
Recommended dose: 200 mg orally twice daily or as prescribed by a hematologist
Take capsules on an empty stomach, at least 1 hour before or 2 hours after meals
Swallow capsules whole; do not crush, chew, or open
Regular blood counts, liver function, and ECG monitoring are required during therapy
Effective targeted therapy for CML
Helps achieve hematologic and cytogenetic remission
Reduces disease progression risk
Well-tolerated with manageable side effects under supervision
Oral therapy allows outpatient treatment and improved quality of life
Inform your doctor if you have:
Heart problems, including arrhythmias or prolonged QT interval
Liver or kidney impairment
History of pancreatitis
Avoid grapefruit or grapefruit juice, which can interfere with drug metabolism
Strict adherence to dosage and monitoring schedule is essential
Common side effects may include:
Fatigue
Nausea or vomiting
Headache
Rash or itching
Serious side effects:
QT interval prolongation or cardiac arrhythmias
Liver enzyme elevation
Pancreatitis
Myelosuppression (low blood counts)
Store at room temperature (20–25°C)
Keep in a dry place, away from light
Keep out of reach of children
Niloren Capsule 200 mg is a targeted, highly effective therapy for Philadelphia chromosome-positive CML. By inhibiting BCR-ABL tyrosine kinase, it helps control leukemia progression, supports remission, and improves long-term outcomes when used under careful medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet